These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38603126)

  • 41. The Judgment of the CJEU of 25 July 2018 on Mutagenesis: Interpretation and Interim Legislative Proposal.
    Vives-Vallés JA; Collonnier C
    Front Plant Sci; 2019; 10():1813. PubMed ID: 32194576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The procurement of NHS dental services--a guide.
    Jones CL; Rooney E
    Br Dent J; 2009 May; 206(10):535-9. PubMed ID: 19461624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Social diversity and access to healthcare in Europe: how does European Union's legislation prevent from discrimination in healthcare?
    Orzechowski M; Nowak M; Bielińska K; Chowaniec A; Doričić R; Ramšak M; Łuków P; Muzur A; Zupanič-Slavec Z; Steger F
    BMC Public Health; 2020 Sep; 20(1):1399. PubMed ID: 32928175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
    Hawkins B; Holden C
    Global Health; 2018 Aug; 14(1):79. PubMed ID: 30071862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subnational responsibilities for healthcare and Austria's rejection of the EU's patients' rights directive.
    Kostera T
    Health Policy; 2013 Jul; 111(2):149-56. PubMed ID: 23602349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Legal regulation of the production and trade of medical devices and medical equipment in the EU and US: experience for Ukraine.
    Pashkov V; Kotvitska A; Harkusha A
    Wiad Lek; 2017; 70(3 pt 2):614-618. PubMed ID: 28713093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison between European Medicines Agency and US Food and Drug Administration in Granting Accelerated Marketing Authorizations for Covid-19 Medicines and their Utilized Regulations.
    Ghadanian M; Schafheutle E
    Ther Innov Regul Sci; 2024 Jan; 58(1):79-113. PubMed ID: 37861859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The architecture of the European Union's pandemic preparedness and response policy framework.
    Eerens D; Hrzic R; Clemens T
    Eur J Public Health; 2023 Feb; 33(1):42-48. PubMed ID: 36399053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. European Health Care Systems and the Emerging Influence of European Union Competition Policy.
    Morton AJB
    J Health Polit Policy Law; 2021 Jun; 46(3):467-486. PubMed ID: 33647978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The European Union, economies and public health: not one without the other.
    Vervoort D; van Daalen KR
    Public Health; 2021 May; 194():1-3. PubMed ID: 33836317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Learning from past pandemic governance: Early response and Public-Private Partnerships in testing of COVID-19 in South Korea.
    Park J; Chung E
    World Dev; 2021 Jan; 137():105198. PubMed ID: 32982017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging food safety issues: An EU perspective.
    McEvoy JD
    Drug Test Anal; 2016 May; 8(5-6):511-20. PubMed ID: 27443205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Public support for European cooperation in the procurement, stockpiling and distribution of medicines.
    Beetsma R; Burgoon B; Nicoli F; de Ruijter A; Vandenbroucke F
    Eur J Public Health; 2021 Apr; 31(2):253-258. PubMed ID: 33454782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. German State Aid for Covid-19 Medicinal Products: A Risk for Solidarity in the European Union.
    Plank K
    Eur J Health Law; 2022 Mar; 29(1):53-78. PubMed ID: 35303719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Directive 2013/11/EU on Consumer ADR Quality: Evidence from France and the UK.
    Biard A
    J Consum Policy (Dordr); 2019; 42(1):109-147. PubMed ID: 31564762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The home bias in procurement. Cross-border procurement of medical supplies during the Covid-19 pandemic.
    Hanspach P
    Int J Ind Organ; 2023 Jun; ():102976. PubMed ID: 37366401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The emerging EU quality of care policy: from sharing information to enforcement.
    Vollaard H; van de Bovenkamp HM; Vrangbæk K
    Health Policy; 2013 Aug; 111(3):226-33. PubMed ID: 23764152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 Lessons and Post-pandemic Recovery: A Case of Latvia.
    Šteinbuka I; Austers A; Barānovs O; Malnačs N
    Front Public Health; 2022; 10():866639. PubMed ID: 35462839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Migration and mobility of third-country national labour workers to and inside Europe during the Covid-19 pandemic - a legal analysis.
    Sommarribas A; Nienaber B
    Comp Migr Stud; 2021; 9(1):22. PubMed ID: 34075331
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.